Last edition
News about "polycythemia vera "
Vanda Pharmaceuticals Receives Orphan Drug Designation Granted for VGT-1849A
VGT-1849A is a novel ASO treatment candidate for PV and other JAK2-driven hematologic malignancies.
Polycythemia Vera | 21/12/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members